Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
$5.12
-1.2%
$5.28
$4.46
$9.20
$967.58M1.3863,489 shs156,221 shs
Arvinas, Inc. stock logo
ARVN
Arvinas
$31.92
-1.9%
$42.34
$13.57
$53.08
$2.18B1.94718,435 shs380,909 shs
Bright Health Group, Inc. stock logo
BHG
Bright Health Group
$6.46
+5.0%
$7.09
$4.94
$82.40
$51.56M0.9372,717 shs2,184 shs
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
$0.67
+2.4%
$0.79
$0.61
$1.63
$329.52M1.848.75 million shs2.36 million shs
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
0.00%+4.65%+11.88%-22.92%-4.60%
Arvinas, Inc. stock logo
ARVN
Arvinas
-4.29%-2.72%-19.99%-13.85%+20.43%
Bright Health Group, Inc. stock logo
BHG
Bright Health Group
-3.39%+4.06%-6.82%-58.86%-54.51%
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
+3.19%+4.55%-17.83%-33.57%-11.18%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
2.7499 of 5 stars
4.21.00.00.01.73.30.6
Arvinas, Inc. stock logo
ARVN
Arvinas
2.713 of 5 stars
4.40.00.00.02.72.50.6
Bright Health Group, Inc. stock logo
BHG
Bright Health Group
N/AN/AN/AN/AN/AN/AN/AN/A
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
1.5381 of 5 stars
3.03.00.00.00.03.30.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
2.44
Hold$9.1879.20% Upside
Arvinas, Inc. stock logo
ARVN
Arvinas
2.88
Moderate Buy$59.7387.13% Upside
Bright Health Group, Inc. stock logo
BHG
Bright Health Group
1.00
Sell$13.00101.24% Upside
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
2.00
Hold$1.50125.46% Upside

Current Analyst Ratings

Latest ALHC, CLOV, BHG, and ARVN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/23/2024
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$11.00 ➝ $9.00
4/12/2024
Arvinas, Inc. stock logo
ARVN
Arvinas
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$90.00 ➝ $87.00
3/25/2024
Arvinas, Inc. stock logo
ARVN
Arvinas
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$65.00
3/6/2024
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
3/6/2024
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageUnderweight$4.50
3/6/2024
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Neutral$12.00 ➝ $6.00
2/29/2024
Arvinas, Inc. stock logo
ARVN
Arvinas
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$26.00 ➝ $60.00
2/28/2024
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$9.00 ➝ $8.50
2/28/2024
Arvinas, Inc. stock logo
ARVN
Arvinas
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$90.00
2/28/2024
Arvinas, Inc. stock logo
ARVN
Arvinas
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$89.00 ➝ $90.00
2/28/2024
Arvinas, Inc. stock logo
ARVN
Arvinas
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$95.00 ➝ $80.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
$1.82B0.53N/AN/A$0.84 per share6.10
Arvinas, Inc. stock logo
ARVN
Arvinas
$78.50M27.78N/AN/A$11.99 per share2.66
Bright Health Group, Inc. stock logo
BHG
Bright Health Group
$2.76B0.02N/AN/A($25.47) per share-0.25
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
$2.03B0.16N/AN/A$0.59 per share1.13

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
-$148.02M-$0.79N/AN/AN/A-8.12%-75.64%-20.36%5/2/2024 (Confirmed)
Arvinas, Inc. stock logo
ARVN
Arvinas
-$367.30M-$6.50N/AN/AN/A-185.09%-70.24%-31.79%5/3/2024 (Estimated)
Bright Health Group, Inc. stock logo
BHG
Bright Health Group
-$1.46B-$208.73N/AN/AN/A-85.40%N/A-10.26%N/A
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
-$213.36M-$0.45N/AN/AN/A-10.49%-62.58%-18.19%5/7/2024 (Confirmed)

Latest ALHC, CLOV, BHG, and ARVN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
-$0.07N/A+$0.07N/AN/AN/A  
5/2/2024N/A
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
-$0.24N/A+$0.24N/AN/AN/A  
3/12/2024Q4 2023
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
-$0.18-$0.12+$0.06-$0.09$491.20 million$510.25 million
2/27/2024Q4 2023
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
-$0.22-$0.25-$0.03-$0.25$444.56 million$465.39 million    
2/27/2024Q4 2023
Arvinas, Inc. stock logo
ARVN
Arvinas
-$1.15-$2.53-$1.38-$2.53$38.91 million($43.10) million  

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
N/AN/AN/AN/AN/A
Arvinas, Inc. stock logo
ARVN
Arvinas
N/AN/AN/AN/AN/A
Bright Health Group, Inc. stock logo
BHG
Bright Health Group
N/AN/AN/AN/AN/A
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
1.02
1.84
1.84
Arvinas, Inc. stock logo
ARVN
Arvinas
N/A
4.98
4.98
Bright Health Group, Inc. stock logo
BHG
Bright Health Group
N/A
1.04
1.04
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
N/A
1.64
1.64

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
86.19%
Arvinas, Inc. stock logo
ARVN
Arvinas
95.19%
Bright Health Group, Inc. stock logo
BHG
Bright Health Group
N/A
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
19.77%

Insider Ownership

CompanyInsider Ownership
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
6.30%
Arvinas, Inc. stock logo
ARVN
Arvinas
5.23%
Bright Health Group, Inc. stock logo
BHG
Bright Health Group
58.40%
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
21.82%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
1,536188.98 million177.07 millionOptionable
Arvinas, Inc. stock logo
ARVN
Arvinas
44568.31 million64.74 millionOptionable
Bright Health Group, Inc. stock logo
BHG
Bright Health Group
2,8407.98 million3.32 millionNot Optionable
Clover Health Investments, Corp. stock logo
CLOV
Clover Health Investments
552495.29 million387.22 millionOptionable

ALHC, CLOV, BHG, and ARVN Headlines

SourceHeadline
Clover Health Investments, Corp.: Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial OfficerClover Health Investments, Corp.: Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer
finanznachrichten.de - April 24 at 4:35 AM
Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024
globenewswire.com - April 23 at 4:05 PM
Clover Health Names Peter Kuipers as New CFOClover Health Names Peter Kuipers as New CFO
marketwatch.com - April 22 at 6:35 PM
Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial OfficerClover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer
globenewswire.com - April 22 at 4:05 PM
Short Interest in Clover Health Investments, Corp. (NASDAQ:CLOV) Drops By 7.5%Short Interest in Clover Health Investments, Corp. (NASDAQ:CLOV) Drops By 7.5%
marketbeat.com - April 16 at 8:37 PM
Clover Mama Afrika’s leader wins for project dedicationClover Mama Afrika’s leader wins for project dedication
sagoodnews.co.za - April 16 at 6:33 AM
The 26 Best Gym Bags For Your Workout EssentialsThe 26 Best Gym Bags For Your Workout Essentials
msn.com - April 9 at 11:07 PM
Clover Health faces delisting threat for 2nd timeClover Health faces delisting threat for 2nd time
beckerspayer.com - April 9 at 11:07 PM
Clover Health settles shareholder lawsuits, enhances governanceClover Health settles shareholder lawsuits, enhances governance
uk.investing.com - April 6 at 7:15 PM
Clover Health Provides Notice Associated with Previously Disclosed Settlement of Shareholder Derivative ActionsClover Health Provides Notice Associated with Previously Disclosed Settlement of Shareholder Derivative Actions
globenewswire.com - April 4 at 4:30 PM
JMP starts HealthEquity at market outperform, cites revenue growthJMP starts HealthEquity at market outperform, cites revenue growth
msn.com - April 4 at 2:34 PM
Video highlights 2023 Greater Muscatine Chamber eventsVideo highlights 2023 Greater Muscatine Chamber events
qctimes.com - April 4 at 9:33 AM
Black Clover chapters 370 and 371 release dateBlack Clover chapters 370 and 371 release date
newscase.com - March 29 at 6:08 PM
Is Black Clover Season 5 Happening? Know in DetailIs Black Clover Season 5 Happening? Know in Detail
devdiscourse.com - March 28 at 9:50 PM
Black Clover Chapters 370 and 371 Release Date & Time (Countdown)Black Clover Chapters 370 and 371 Release Date & Time (Countdown)
beebom.com - March 28 at 4:48 PM
Cautious Optimism on Clover Health’s Performance with Concerns on Long-Term ProfitabilityCautious Optimism on Clover Health’s Performance with Concerns on Long-Term Profitability
markets.businessinsider.com - March 21 at 10:29 AM
Insider Spends US$110k Buying More Shares In Clover Health InvestmentsInsider Spends US$110k Buying More Shares In Clover Health Investments
finance.yahoo.com - March 20 at 7:28 PM
3 Under-the-Radar Stocks to Transform $10K into $100K by 20283 Under-the-Radar Stocks to Transform $10K into $100K by 2028
investorplace.com - March 20 at 4:30 PM
Health insurers retreat from ACO REACHHealth insurers retreat from ACO REACH
modernhealthcare.com - March 19 at 2:50 PM
Clover Health Launches New Clinical Program in Partnership with Quartet Health to Address Serious Mental IllnessClover Health Launches New Clinical Program in Partnership with Quartet Health to Address Serious Mental Illness
globenewswire.com - March 19 at 9:00 AM
Clover Health Investments, Corp. (NASDAQ:CLOV) Director Acquires $100,010.00 in StockClover Health Investments, Corp. (NASDAQ:CLOV) Director Acquires $100,010.00 in Stock
insidertrades.com - March 19 at 5:18 AM
Downgrade: Heres How Analysts See Clover Health Investments, Corp. (NASDAQ:CLOV) Performing In The Near TermDowngrade: Here's How Analysts See Clover Health Investments, Corp. (NASDAQ:CLOV) Performing In The Near Term
finance.yahoo.com - March 18 at 9:54 AM
CLOV Mar 2024 2.000 callCLOV Mar 2024 2.000 call
finance.yahoo.com - March 15 at 11:33 PM
Peering Into Clover Health Investmentss Recent Short InterestPeering Into Clover Health Investments's Recent Short Interest
benzinga.com - March 15 at 1:33 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Alignment Healthcare logo

Alignment Healthcare

NASDAQ:ALHC
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Arvinas logo

Arvinas

NASDAQ:ARVN
Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company engineers proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. Its product pipeline includes Bavdegalutamide and ARV-766, investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer, which are in Phase 1/2 clinical trials; and ARV-471, an orally bioavailable estrogen receptor degrading PROTAC targeted protein degrader for the treatment of patients with locally advanced or metastatic estrogen receptor+/human epidermal growth factor receptor 2-breast cancer, which is Phase 3 clinical trial. Arvinas, Inc. has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., Carrick Therapeutics Limited, and Bayer AG. The company was founded in 2013 and is based in New Haven, Connecticut.
Bright Health Group logo

Bright Health Group

NYSE:BHG
Bright Health Group, Inc., a healthcare company, provides health insurance policies in the United States. It operates in two segments, Bright HealthCare and Consumer Care. The Consumer Care segment delivers virtual and in-person clinical care services contracts through primary care clinics. It operates managed and affiliated risk-bearing clinics within its integrated care delivery system, which included embedded pharmacy, laboratory, radiology, and population health focused specialty services. The Bright HealthCare segment offers medicare health plan products to consumers. The company was formerly known as Bright Health Inc. and changed its name to Bright Health Group, Inc. in February 2021. Bright Health Group, Inc. was incorporated in 2015 and is headquartered in Minneapolis, Minnesota.
Clover Health Investments logo

Clover Health Investments

NASDAQ:CLOV
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.